Methods for Rational Development of Vaccines and Ribotype-Based Speciation

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		97-41
IP Type:		Licensable Technology
Title:		Methods for Rational Development of Vaccines and Ribotype-Based Speciation
Inventor:		Goldstein, Richard
Summary:		The invention allows for a rapid and inexpensive evaluation of a vaccine target, without resorting to Òtrial and errorÓ with animal testing. . It determines a statistically significant number of different strains within a species of bacteria indicative of the specific population structure. The invention contemplates the establishment of an initial phylogenic analysis of any bacterial pathogen of interest. With an acccurate phylogenic picture of any particular species of bacteria, one skilled in the art of vaccine target evaluation can proceed with a survey for variability of a large number of possible antigen vaccine target candidates. Thus this method saves enormous time and expense otherwise involved in animal testing.
Tech Type:		Vaccines \| Drug Discovery Tools
URL:		http://ctf-fmfe.bu.edu/NoPDF.htm
Contact:		Rick T. Clark, rclark@bu.edu, 617 358 4208
Organization:		Boston University

Display all intellectual properties for Goldstein, Richard
Display all intellectual properties for Boston University